ZD1839(Iressa(R)) 복용 후 발생한 여드름모양 발진 1예A case of acneiform skin eruption associated with ZD1839(Iressa®)
- Other Titles
- A case of acneiform skin eruption associated with ZD1839(Iressa®)
- Authors
- 김용주; 황규철; 유동수; 오칠환; 송해준
- Issue Date
- Apr-2004
- Publisher
- Korean Dermatological Association
- Keywords
- Acneiform eruption; ZD1839
- Citation
- Korean Journal of Dermatology, v.42, no.4, pp 478 - 481
- Pages
- 4
- Indexed
- SCOPUS
KCI
- Journal Title
- Korean Journal of Dermatology
- Volume
- 42
- Number
- 4
- Start Page
- 478
- End Page
- 481
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/32256
- ISSN
- 0494-4739
2713-7627
- Abstract
- Epidermal growth factor (EGF) has an important role in the regulation of the proliferation and differentiation of epidermal keratinocytes, as well as in the survival, angiogenesis and metastasis of various cancer cells. There have been some reports of acneiform skin lesions that occurred in the cancer patients treated with ZD1839(Iressa®), an inhibitor of EGF tyrosine kinase. We report a case of acneiform eruption related to the anticancer drug, ZD1839(Iressa®).
Epidermal growth factor (EGF) has an important role in the regulation of the proliferation and differentiation of epidermal keratinocytes, as well as in the survival, angiogenesis and metastasis of various cancer cells. There have been some reports of acneiform skin lesions that occurred in the cancer patients treated with ZD1839(Iressa®), an inhibitor of EGF tyrosine kinase. We report a case of acneiform eruption related to the anticancer drug, ZD1839(Iressa®).
- Files in This Item
-
Go to Link
- Appears in
Collections - 2. Clinical Science > Department of Dermatology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.